Raycome Bags ￥55M in Series B+ Round of Funding

According to VCBeat, Shenzhen Raycome Health Technology Co., Ltd. ("Raycome") has bagged 55 million yuan in Series B+ round of funding, led by Oriental Fortune Capital. The person in charge of Raycome said that the funds raised will be used for online operation, offline marketing, international trade, development of an online blood pressure management system to create comprehensive health care 'ecosystem'.

Established in April 2008, Raycome is a high-tech enterprise specializing in research, development, production and sales of blood pressure measurement and laser therapy devices.

In 2011, Raycome started R&D on accurate blood pressure measurement technology and launched the 4th generation pulsewave blood pressure monitors into the market. It using innovative patent dual-balloons/sensors technology (instead of other single balloon/sensor ordinary digital blood pressure devices) and continuous measurement of multi-point pressure between pulses to achieve the most accurate measurement during the record of the accurate real state of blood flow. Over 40 countries invention patent applied.

Raycome is the only provider of integration solutions based on software and hardware for total blood pressure in the world. Its pulsewave blood pressure monitoring devices are used widely in hospitals. The market share of the products is far ahead in the segments of the medical industry such as smart healthcare and hemodialysis.

Raycome also developed a client software APP named 'BP Secretary' for health data management. On the basis of accurate blood pressure figures, this APP supplying professional and long-term health management service. It covers clinical use/OTC/Mobile models. The company is committed to developing an online blood pressure management system to provide comprehensive services such as self-service blood pressure measurement, real-time blood pressure monitoring, data statistics and analysis, health alert and life guidance. 

Founded in 2006, OFC manages 42 funds with AUM of more than 20 billion yuan. OFC invests in small and medium-sized growth-oriented companies. Its funds cover five industries: Telecommunication, Media & Technology (TMT), Green Technology, New Material & Advanced Manufacturing Technology, Healthcare, and Entertainment & Consumption. The company invests in various business development stages through the angel, venture capital, and private equity investment vehicles.